Click for Philadelphia, Pennsylvania Forecast
HOME ISSUE

CALENDAR

BETWEEN ISSUES ARCHIVE DEADLINES CONTACT USFAQS
 
 
Print This Issue
Front Page
Contents
Crimes
Directory
All About Teaching
Subscribe to E-Alamanc!
Staffbox
Guidelines
 

 

ITMAT Seed Grants: January 10

The Institute for Translational Medicine and Therapeutics (ITMAT) has extended the deadline for our seed grant program (TAPITMAT) from December 1, 2005 to January 10, 2006. Only ITMAT Members and ITMAT Associate Members in the Research Associate or Instructor A category are eligible to apply for this funding. It is not too late to become a Member or an Associate Member.  If you are interested, please visit the membership section of our website (www.itmat.upenn.edu/membership.shtml) for details.

ITMAT plans to support translational research through a Transdisciplinary Awards Program In Translational Medicine And Therapeutics (TAPITMAT). Initially, we shall consider funding four to six proposals in the region of $100,000-$150,000. These proposals require at least two Co-Principal Investigators, ideally from different disciplines within the University of Pennsylvania, at least one of whom has a primary appointment in the School of Medicine. The proposals must center on the translational space-from proof of concept in cells or model systems through to completion of dose selection in Phase II in humans. Programs that plan to progress within that space and which deploy technologies and approaches conventionally segregated from each other within the traditional boundaries of academic medicine will be especially favored.  The proposals are due by January 10, 2006 for a proposal start date of February 1, 2006. For more information, please visit our website at www.itmat.upenn.edu.

— Garret A. FitzGerald, Director, ITMAT

 



 
  Almanac, Vol. 52, No. 14, December 6, 2005

ISSUE HIGHLIGHTS:

Tuesday,
December 6, 2005
Volume 52 Number 14
www.upenn.edu/almanac

 

top of page
Back to Contents page
HOME ISSUE CALENDAR BETWEEN ISSUES ARCHIVE DEADLINES CONTACT USFAQS